p.128 抽出テキスト

investigation. Circ J 2005; 69: 1237–1243. PMID: 16195624 613. Shiga T, Tanaka K, Kato R, et al. Refractory VT/VF, Prospective Evaluation to Differentiate Lidocaine Efficacy from Nifekalant (RELIEF) Study Investigators. Nifekalant versus lidocaine for in-hospital shock-resistant ventricular fibrillation or tachycardia. Resuscitation 2010; 81: 47–52. PMID: 19913983 614. Tahara Y, Kimura K, Kosuge M, et al. Comparison of nifekalant and lidocaine for the treatment of shock-refractory ventricular fibrillation. Circ J 2006; 70: 442–446. PMID: 16565562 615. Amino M, Inokuchi S, Nagao K, et al. SOS-KANTO 2012 Study Group. Nifekalant Hydrochloride and Amiodarone Hydrochloride Result in Similar Improvements for 24-Hour Survival in Cardiopulmonary Arrest Patients: The SOS-KANTO 2012 Study. J Cardiovasc Pharmacol 2015; 66: 600–609. PMID: 26317166 616. Dumas F, Cariou A, Manzo-Silberman S, et al. Immediate percutaneous coronary intervention is associated with better survival after out-of-hospital cardiac arrest: insights from the PROCAT (Parisian Region Out of hospital Cardiac ArresT) registry. Circ Cardiovasc Interv 2010; 3: 200–207. PMID: 20484098 617. Nordrehaug JE, Johannessen KA, von der Lippe G. Serum potassium concentration as a risk factor of ventricular arrhythmias early in acute myocardial infarction. Circulation 1985; 71: 645–649. PMID: 3971535 618. Kurisu S, Inoue I, Kawagoe T, et al. Temporary overdriving pacing as an adjunct to antiarrhythmic drug therapy for electrical storm in acute myocardial infarction. Circ J 2005; 69: 613–616. PMID: 15849451 619. Bänsch D, Oyang F, Antz M, et al. Successful catheter ablation of electrical storm after myocardial infarction. Circulation 2003; 108: 3011–3016. PMID: 14662718 620. Hayashi M, Kobayashi Y, Iwasaki YK, et al. Novel mechanism of postinfarction ventricular tachycardia originating in surviving left posterior Purkinje fibers. Heart Rhythm 2006; 3: 908–918. PMID: 16876739 621. Gorenek B, Blomström Lundqvist C, Brugada Terradellas J, et al. Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force. Europace 2014; 16: 1655–1673. PMID: 25172845 622. Piccini JP, Schulte PJ, Pieper KS, et al. Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction. Crit Care Med 2011; 39: 78–83. PMID: 20959785 623. Gheeraert PJ, De Buyzere ML, Taeymans YM, et al. Risk factors for primary ventricular fibrillation during acute myocardial infarction: a systematic review and meta-analysis. Eur Heart J 2006; 27: 2499–2510. PMID: 16952926 624. Liang JJ, Fender EA, Cha YM, et al. Long-Term Outcomes in Survivors of Early Ventricular Arrhythmias After Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention. Am J Cardiol 2016; 117: 709–713. PMID: 26796195 625. Masuda M, Nakatani D, Hikoso S, et al. OACIS investigators. Clinical Impact of Ventricular Tachycardia and/or Fibrillation During the Acute Phase of Acute Myocardial Infarction on In-Hospital and 5-Year Mortality Rates in the Percutaneous Coronary Intervention Era. Circ J 2016; 80: 1539–1547. PMID: 27238618 626. Hjalmarson A. Effects of beta blockade on sudden cardiac death during acute myocardial infarction and the postinfarction period. Am J Cardiol 1997; 80: 35J–39J. PMID: 9375948 627. Nademanee K, Taylor R, Bailey WE, et al. Treating electrical storm : sympathetic blockade versus advanced cardiac life supportguided therapy. Circulation 2000; 102: 742–747. PMID: 10942741 628. Miwa Y, Ikeda T, Mera H, et al. Effects of landiolol, an ultra-shortacting beta1-selective blocker, on electrical storm refractory to class III antiarrhythmic drugs. Circ J 2010; 74: 856–863. PMID: 20339194 629. Burjorjee JE, Milne B. Propofol for electrical storm; a case report of cardioversion and suppression of ventricular tachycardia by propofol. Can J Anaesth 2002; 49: 973–977. PMID: 12419728 630. Hine LK, Laird N, Hewitt P, et al. Meta-analytic evidence against prophylactic use of lidocaine in acute myocardial infarction. Arch Intern Med 1989; 149: 2694–2698. PMID: 2688587 631. Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias. N Engl J Med 2001; 345: 1473–1482. PMID: 11794197 632. Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991; 324: 781–788. PMID: 1900101 633. Wever EF, Hauer RN, van Capelle FL, et al. Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors. Circulation 1995; 91: 2195–2203. PMID: 7697849 634. Siebels J, Kuck KH. Implantable cardioverter defibrillator

compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg). Am Heart J 1994; 127: 1139–1144. PMID: 8160593 635. Connolly SJ, Hallstrom AP, Cappato R, et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study. Eur Heart J 2000; 21: 2071–2078. PMID: 11102258 636. 日本不整脈心電学会.着用型自動除細動器(WCD)の臨床使用に関するステートメント(2017 年9 月改訂) .http://new.jhrs. or.jp/pdf/guideline/statement201709_02.pdf 637. Crijns HJ, Weijs B, Fairley AM, et al. Contemporary real life cardioversion of atrial fibrillation: Results from the multinational RHYTHM-AF study. Int J Cardiol 2014; 172: 588–594. PMID: 24556445 638. Coll-Vinent B, Sala X, Fernández C, et al. Sedation for cardioversion in the emergency department: analysis of effectiveness in four protocols. Ann Emerg Med 2003; 42: 767–772. PMID: 14634601 639. del Arco C, Martín A, Laguna P, et al. Investigators in the Spanish Atrial Fibrillation in Emergency Medicine Study Group (GEFAUR). Analysis of current management of atrial fibrillation in the acute setting: GEFAUR-1 study. Ann Emerg Med 2005; 46: 424–430. PMID: 16271674 640. Scheuermeyer FX, Grafstein E, Heilbron B, et al. Emergency department management and 1-year outcomes of patients with atrial flutter. Ann Emerg Med 2011; 57: 564–571.e2. PMID: 21257230 641. You JJ, Singer DE, Howard PA, et al. Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 Suppl: e531S–e575S. PMID: 22315271 642. Nikolaidou T, Channer KS. Chronic atrial fibrillation: a systematic review of medical heart rate control management. Postgrad Med J 2009; 85: 303–312. PMID: 19528305 643. Kirchhof P, Benussi S, Kotecha D, et al. ESC Scientific Document Group. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016; 37: 2893–2962. PMID: 27567408 644. Hanada K, Higuma T, Nishizaki F, et al. Randomized study on the efficacy and safety of landiolol, an ultra-short-acting β1-adrenergic blocker, in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Circ J 2012; 76: 439–445. PMID: 22156314 645. Kiyokuni M, Konishi M, Sakamaki K, et al. Beneficial effect of early infusion of landiolol, a very short-acting beta-1 adrenergic receptor blocker, on reperfusion status in acute myocardial infarction. Int J Cardiol 2016; 221: 321–326. PMID: 27404699 646. Moss AJ, Oakes D, Benhorin J, et al. Multicenter Diltiazem Post-Infarction Research Group. The interaction between diltiazem and left ventricular function after myocardial infarction. Circulation 1989; 80 Suppl: IV102–IV106. PMID: 2688978 647. Camm AJ, Capucci A, Hohnloser SH, et al. AVRO Investigators. A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation. J Am Coll Cardiol 2011; 57: 313–321. PMID: 21232669 648. Deedwania PC, Singh BN, Ellenbogen K, et al. The Department of Veterans Affairs CHF-STAT Investigators. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). Circulation 1998; 98: 2574–2579. PMID: 9843465 649. Clemo HF, Wood MA, Gilligan DM, et al. Intravenous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias. Am J Cardiol 1998; 81: 594–598. PMID: 9514456 650. January CT, Wann LS, Alpert JS, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2014; 64: e1–76. PMID: 24685669 651. Ziff OJ, Lane DA, Samra M, et al. Safety and efficacy of digoxin: